Ryan Hakim
Neurology Residency · University of Arizona College of Medicine-Tucson
Credentials: · ·
History
Research
Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab
Alzheimer s & Dementia · 2026 · First of 9 authors · Corresponding
Journal of Pharmacy Practice · 2024 · First of 4 authors
Letter or commentary · Journal of Endourology · 2021 · 8 citations
1 paper
1 paper
- DS
1 paper
1 paper
- EV
1 paper
- MG
1 paper
- OO
1 paper · 1 as a resident
1 paper
